Avapag 20 mg (Avatrombopag) is a thrombopoietin receptor agonist used to treat thrombocytopenia in patients with chronic liver disease or chronic immune thrombocytopenia. It stimulates platelet production to reduce bleeding risk. Common side effects include headache, fever, fatigue, and nausea. Use under medical supervision. https://oncomedicure.com/product/avapag-20-mg-avatrombopag/